PATENT MISUSE THROUGH the CAPTURE of INDUSTRY STANDARDS by Janice M
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
MPEP Identifying and Evaluating Each Claim Limitation
Chapter 2100 Patentability 2101 [Reserved] 2121.03 Plant Genetics Ð What Constitutes -2102 Enabling Prior Art 2103 Patent Examination Process 2121.04 Apparatus and Articles Ð What 2104 Patentable Subject Matter Constitutes Enabling Prior Art 2105 Patentable Subject Matter Ð Living 2122 Discussion of Utility in the Prior Art Subject Matter 2123 Rejection Over Prior Art's Broad 2106 Patent Subject Matter Eligibility Disclosure Instead of Preferred 2106.01 [Reserved] Embodiments 2107 Guidelines for Examination of 2124 Exception to the Rule That the Critical Applications for Compliance with the Reference Date Must Precede the Filing Utility Requirement Date 2107.01 General Principles Governing Utility 2124.01 Tax Strategies Deemed Within the Rejections Prior Art 2107.02 Procedural Considerations Related to 2125 Drawings as Prior Art Rejections for Lack of Utility 2126 Availability of a Document as a 2107.03 Special Considerations for Asserted ªPatentº for Purposes of Rejection Therapeutic or Pharmacological Under 35 U.S.C. 102(a) or Pre-AIA 35 Utilities U.S.C. 102(a), (b), and (d) 2108 [Reserved] 2126.01 Date of Availability of a Patent as a -2110 Reference 2111 Claim Interpretation; Broadest 2126.02 Scope of Reference's Disclosure Reasonable Interpretation Which Can Be Used to Reject Claims 2111.01 Plain Meaning When the Reference Is a ªPatentº but 2111.02 Effect of Preamble Not a ªPublicationº 2111.03 Transitional Phrases 2127 Domestic and Foreign Patent 2111.04 ªAdapted to,º ªAdapted for,º Applications as Prior Art ªWherein,º and ªWherebyº Clauses 2128 ªPrinted Publicationsº as Prior Art 2111.05 Functional and Nonfunctional 2128.01 Level of Public Accessibility Descriptive Material Required 2112 Requirements of Rejection Based on 2128.02 Date Publication Is Available as a Inherency; Burden of Proof Reference 2112.01 Composition, Product, and Apparatus 2129 Admissions as Prior Art Claims 2130 [Reserved] 2112.02 Process Claims 2131 Anticipation Ð Application of 35 U.S.C. -
Patents and the Public Domain: Improving Patent Quality Upon Reexamination
Patents and the Public Domain: Improving Patent Quality Upon Reexamination Prepared by Policy Intern Raeanne Young [email protected] May 2008 ELECTRONIC FRONTIER FOUNDATION eff.org Table of Contents EXECUTIVE SUMMARY ........................................................................................................................3 PATENTS AND THE PUBLIC DOMAIN .....................................................................................................4 The Problem With Patent Quality ..................................................................................................4 Policy Rationale: Encouraging Innovation .......................................................................................4 PATENT REEXAMINATION ...................................................................................................................6 Ex parte and Inter partes .............................................................................................................6 OVERALL REEXAMINATION TRENDS ......................................................................................................8 Ex Parte Reexamination Filing Data: July , 98 - December 3, 2007 ...............................................8 Inter Partes Reexamination Filing Data: November 29, 999 - December 3, 2007 .............................0 Comparison of Ex Parte and Inter Partes ......................................................................................0 PROMOTING FAIRNESS IN THE PATENT SYSTEM THROUGH REEXAMINATION .............................................2 -
Patents and Monopolization: the Role of Patents Under Section Two of the Sherman Act Ramon A
Marquette Law Review Volume 68 Article 2 Issue 4 Summer 1985 Patents and Monopolization: The Role of Patents Under Section Two of the Sherman Act Ramon A. Klitzke Follow this and additional works at: http://scholarship.law.marquette.edu/mulr Part of the Law Commons Repository Citation Ramon A. Klitzke, Patents and Monopolization: The Role of Patents Under Section Two of the Sherman Act, 68 Marq. L. Rev. 557 (1985). Available at: http://scholarship.law.marquette.edu/mulr/vol68/iss4/2 This Article is brought to you for free and open access by the Journals at Marquette Law Scholarly Commons. It has been accepted for inclusion in Marquette Law Review by an authorized administrator of Marquette Law Scholarly Commons. For more information, please contact [email protected]. PATENTS AND MONOPOLIZATION: THE ROLE OF PATENTS UNDER SECTION TWO OF THE SHERMAN ACT RAMON A. KLITZKE* Section Two of the Sherman Act1 proscribes monopoliza- tion, a broad, ambiguous term that is susceptible of myriads of diverse interpretations in the complex world of business com- petition. Perceptions of monopolization as unlawful, anticom- petitive behavior vary widely, depending upon the various competitive methods utilized to achieve the monopolization. Some of these methods, such as the patent grant, are explicitly sanctioned by statutes and are therefore not unlawful. The patent grant, which is ostensibly a legal monopoly, 2 can be forged by its owner into a most powerful anticompetitive weapon that may be used to transcend the legal limits of its use. In numerous ways it may become a principal actor in the monopolization that is prohibited by Section Two. -
An Empirical Study of the Effects of Ex Ante Licensing Disclosure Policies on the Development of Voluntary Technical Standards
An Empirical Study of the Effects of Ex Ante Licensing Disclosure Policies on the Development of Voluntary Technical Standards by Jorge L. Contreras American University Washington College of Law Washington, DC for NISI National Institute of Standards and Technology U.S. Department of Commerce NIST Standards Services Group Under NIST Contract No. SB134110SEI033 This publication was produced as part of contract SB134110SEI033 with the National Institute of Standards and Technology. The contents of this publication do not necessarily reflect the views or policies of the National Institute of Standards and Technology or the U.S. Government. GCR 11-934 Release Date: June 27, 2011 An Empirical Study of the Effects of Ex Ante Licensing Disclosure Policies on the Development of Voluntary Technical Standards Jorge L. Contreras Table of Contents Acknowledgements and Statement of Interests I. Executive Summary II. Background A. Development of Voluntary Technical Standards B. Patent Hold-Up in Standards-Setting C. SDO Patent Policies D. FRAND Licensing Requirements E. Ex Ante Disclosure ofLicensing Terms as a Proposed Solution F. Criticisms ofEx Ante Policy Policies G. SDO Adoption and Consideration ofEx Ante Policies 1. VITA 2. IEEE 3. ETSJ 4. Consortia (W3C and NGMN) 5. JETF and "Informal" Ex Ante Approaches III. Study Aims and Methodology A. Study Aims B. Methodology 1. SDOs Selected 2. Time Period 3. Historical Data 4. Survey Data IV. Findings and Analysis A. SDO Patent and Licensing Disclosures B. Number ofStandards C. Length ofStandardization Process D. Personal Time Commitment E. Membership F. Quality ofStandards G. Effect on Royalty Rates V. Conclusions Data Appendices List of References Ex Ante Standards Study Report Page i June 27,2011 Acknowledgements This study was funded by the u.s. -
ANTITRUST ENFORCEMENT and INTELLECTUAL PROPERTY RIGHTS: Promoting Innovation and Competition
ANTITRUST ENFORCEMENT AND INTELLECTUAL PROPERTY RIGHTS: Promoting Innovation and Competition ISSUED BY THE U.S. DEPARTMENT OF JUSTICE AND THE FEDERAL TRADE COMMISSION APRIL 2007 This Report should be cited as: U.S. DEP’T OF JUSTICE & FED. TRADE COMM’N, ANTITRUST ENFORCEMENT AND INTELLECTUAL PROPERTY RIGHTS: PROMOTING INNOVATION AND COMPETITION (2007). This Report can be accessed electronically at: www.usdoj.gov/atr/public/hearings/ip/222655.pdf www.ftc.gov/reports/index.shtm TABLE OF CONTENTS INTRODUCTION ................................................................. 1 CHAPTER 1: THE STRATEGIC USE OF LICENSING: UNILATERAL REFUSALS TO LICENSE PATENTS ................................................. 15 I. Introduction ......................................................... 15 II. The Kodak and CSU Decisions .......................................... 16 A. The Basic Facts and Holdings of the Cases .................. 16 B. Panelist Views on Kodak .................................. 17 C. Panelist Views on CSU ................................... 18 D. Ambiguity as to the Scope of the Patent Grant .............. 19 III. Policy Issues Relating to Unilateral Refusals to License ................... 20 A. Should Antitrust Law Accord Special Treatment to Patents? .. 21 B. Should Market Power Be Presumed with Patents? ........... 22 C. If an Antitrust Violation Were Found, Would There Be Workable Remedies for Unconditional, Unilateral Refusals to License Patents? .............................. 22 D. What Would Be the Effect of Liability for -
The “Article of Manufacture” Today
Harvard Journal of Law & Technology Volume 31, Number 2 Spring 2018 THE “ARTICLE OF MANUFACTURE” TODAY Sarah Burstein* TABLE OF CONTENTS I. INTRODUCTION .............................................................................. 782 II. BACKGROUND .............................................................................. 785 A. Design Patentable Subject Matter ............................................ 785 B. Design Patent Claiming & Infringement ................................. 786 C. Remedies for Design Patent Infringement ............................... 788 III. WHAT IS THE “ARTICLE OF MANUFACTURE” IN § 289?.............. 789 A. The Apple/Nordock Rule .......................................................... 791 B. The Supreme Court Weighs In ................................................. 791 IV. WHY COURTS SHOULD NOT ADOPT THE GOVERNMENT’S APPROACH .................................................................................... 793 A. The Test .................................................................................... 794 1. The Underlying Premise ........................................................ 795 2. The Factors ............................................................................ 797 B. The Nature of the Inquiry ......................................................... 802 1. A Case-by-Case Inquiry? ...................................................... 802 2. Is it a Question of Fact or Law? ............................................ 807 C. The Burden of Proof................................................................ -
Insufficiency of Antitrust As a Test for Patent Misuse
The Insufficie ncy of Antitrust Analysis for Patent Misuse Robin C. Feldman* Patent misuse lies at the intersection of patent and antitrust law. The history and conceptual overlap of patent law and antitrust law have left the doctrine of misuse hopelessly entangled with antitrust doctrines. In response, a number of scholars and legislators have argued for streamlin- ing the patent misuse inquiry by applying antitrust rules.1 Current court decisions have moved in this direction as well.2 The notion of applying antitrust rules to test for patent misuse has an appealing logic. Patent misuse can be defined as an improper attempt to expand a patent. Antitrust principles, among other things, restrict the improper expansion of monopolies. Shouldn’t courts be able to use anti- trust rules to identify an improper expansion of a patent monopoly? * Assistant Professor, U.C. Hastings College of the Law. I wish to thank Margreth Barrett, John Barton, Ash Bhagwat, Dan Burk, June Carbone, David Earp, Susan Freiwald, Paul Goldstein, Matthew Greene, Herbert Hovenkamp, Jeff Lefstin, Mark Lemley, Maura Rees, Ernest Young, and participants in the 2003 Intellectual Property Scholars’ Conference for their comments on prior drafts. I am grateful beyond measure to Linda Weir, U.C. Hastings Public Services Librarian, for her research and insights. I am also indebted to Amy Hsiao for research assistance on antitrust and to Gary Chang and Daniel Wan for research assistance on Reach-Through Royalties. 1. See, e.g., USM Corp. v. SPS Technologies, Inc., 694 F.2d 505, 512 (7th Cir. 1982); Windsurfing Int’l Inc. v. -
Journal of Legal Technology Risk Management
THIRD CIRCUIT USES PROCEDURAL GROUNDS i JOURNAL OF LEGAL TECHNOLOGY RISK MANAGEMENT 1. THIRD CIRCUIT USES PROCEDURAL GROUNDS TO REJECT FCC’S WEAKENING OF MEDIA CROSS-OWNERSHIP RULES FOR A SECOND TIME IN PROMETHEUS RADIO PROJECT V. FCC 2. WHEN PARALLEL TRACKS CROSS: APPLICATION OF THE NEW INSIDER TRADING REGULATIONS UNDER DODD-FRANK DERAILS 3. ELECTRONIC DISCOVERY AND THE CONSTITUTION: INACCESSIBLE JUSTICE 4. RENEWING THE BAYH-DOLE ACT AS A DEFAULT RULE IN THE WAKE OF STANFORD V. ROCHE Volume 6 | Summer 2012 | Issue 1 (c) 2006-2012 Journal of Legal Technology Risk Management. All Rights Reserved. ISSN 1932-5584 (Print) | ISSN 1932-5592 (Online) | ISSN 1932-5606 (CD-ROM) www.ltrm.org II J. OF LEGAL TECH. AND RISK MGMT [Vol. 6 Editor-in-Chief Daniel B. Garrie, Esq. (USA) Guest Editor Kelly Merkel, Esq. (USA) Publications Editor Candice M. Lang, Esq. (USA) Executive Editors Matthew Armstrong, Esq. (USA) Dr. Sylvia Mercado Kierkegaard (Denmark) Scientific Council Stephanie A. “Tess” Blair, Esq. (USA) Hon. Amir Ali Majid (UK) Hon. Maureen Duffy-Lewis (USA) Micah Lemonik (USA) Andres Guadamuz (UK ) Carlos Rohrmann, Esq. (Brazil) Camille Andrews, Esq. (USA) Gary T. Marx (USA) William Burdett (USA) Eric A. Capriloi (France) Donald P. Harris (USA) Hon. Justice Ivor Archie (Trinidad & Tobago) ii Members Janet Coppins (USA) Eleni Kosta (Belgium) Dr. Paolo Balboni (Italy) Salvatore Scibetta, Esq. (USA) Ygal Saadoun (France/Egypt) Steve Williams, Esq. (USA) Rebecca Wong (United Kingdom) iii IV J. OF LEGAL TECH. AND RISK MGMT [Vol. 6 FOREWORD In this edition, we explore seemingly disparate realms of regulation and legislation and discover shared nuances in growing concern for current legal framework in all facets of legal practice and scholarship. -
Bayh-Dole of United States for Purposes of This Chapter by Execu- Act
§ 187 TITLE 35—PATENTS Page 88 tion is amended by striking ‘‘of this title’’ each CHAPTER 18—PATENT RIGHTS IN INVEN- place that term appears. See 2011 Amendment TIONS MADE WITH FEDERAL ASSISTANCE note below. Sec. HISTORICAL AND REVISION NOTES 200. Policy and objective. Based on Title 35, U.S.C., 1946 ed., § 156 (Feb. 1, 1952, 201. Definitions. ch. 4, § 6, 66 Stat. 5, 6). 202. Disposition of rights. Language is changed. 203. March-in rights. 204. Preference for United States industry. AMENDMENTS 205. Confidentiality. 2011—Pub. L. 112–29 struck out ‘‘of this title’’ after 206. Uniform clauses and regulations. ‘‘181’’ and after ‘‘184’’. 207. Domestic and foreign protection of federally 1988—Pub. L. 100–418, which directed the insertion of owned inventions. ‘‘willfully’’ after second reference to ‘‘whoever’’, was 208. Regulations governing Federal licensing. executed by making the insertion after ‘‘or whoever’’, 209. Licensing federally owned inventions. as the probable intent of Congress. 210. Precedence of chapter. 211. Relationship to antitrust laws. EFFECTIVE DATE OF 2011 AMENDMENT 212. Disposition of rights in educational awards. Amendment by Pub. L. 112–29 effective upon the expi- AMENDMENTS ration of the 1-year period beginning on Sept. 16, 2011, and applicable to proceedings commenced on or after 2000—Pub. L. 106–404, § 4(b), Nov. 1, 2000, 114 Stat. 1744, that effective date, see section 20(l) of Pub. L. 112–29, substituted ‘‘Licensing federally owned inventions’’ for set out as a note under section 2 of this title. ‘‘Restrictions on licensing of federally owned inven- tions’’ in item 209. -
Viral Licensing: Ensuring the Public Interest When Taxpayers Fund Pharmaceutical Research
Santa Clara Law Review Volume 59 Number 3 Article 6 2-6-2020 VIRAL LICENSING: ENSURING THE PUBLIC INTEREST WHEN TAXPAYERS FUND PHARMACEUTICAL RESEARCH Feldman, Robin C. Change-Rowe, Betty Oral, Rabiah Follow this and additional works at: https://digitalcommons.law.scu.edu/lawreview Part of the Law Commons Recommended Citation Feldman, Robin C.; Change-Rowe, Betty; and Oral, Rabiah, VIRAL LICENSING: ENSURING THE PUBLIC INTEREST WHEN TAXPAYERS FUND PHARMACEUTICAL RESEARCH, 59 SANTA CLARA L. REV. 641 (2020). Available at: https://digitalcommons.law.scu.edu/lawreview/vol59/iss3/6 This Article is brought to you for free and open access by the Journals at Santa Clara Law Digital Commons. It has been accepted for inclusion in Santa Clara Law Review by an authorized editor of Santa Clara Law Digital Commons. For more information, please contact [email protected], [email protected]. VIRAL LICENSING: ENSURING THE PUBLIC INTEREST WHEN TAXPAYERS FUND PHARMACEUTICAL RESEARCH Robin C. Feldman,* Betty Change Rowe,** & Rabiah Oral*** In recent years, the nation’s drug development and delivery system has loomed in the forefront of pressing policy concerns. This piece suggests a relatively simple pathway that could provide opportunities for progress with aspects of the problem. Through the addition of a few choice provisions in their licensing agreements, research universities could improve consumer choices and access to the drugs developed with their government-funded research. Looking at the entire drug development system, universities play a complex set of roles. They are both the keepers of the academic flame and the stewards of public money. Beyond that, universities also may benefit from the substantial royalty dollars that flow when pharmaceutical companies purchase licenses. -
2200 Citation of Prior Art and Reexamination of Patents
Chapter 2200 Citation of Prior Art and Reexamination of Patents Citation of Prior Art and Reexamination of Patents 2247 Decision on Request for Reexamination, 2201 Introduction Request Denied 2202 Citation of Prior Art 2247.01 Examples of Decisions on Request for 2203 Persons Who May Cite Prior Art Reexamination 2204 Time for Filing Prior Art Citation 2248 Petition From Denial of Request 2205 Content of Prior Art Citation 2249 Patent Owner's Statement 2206 Handling of Prior Art Citation 2250 Amendment by Patent Owner 2207 Entry of Court Decision in Patent File 2250.01 Correction of Patent Drawings 2208 Service of Citation on Patent Owner 2251 Reply by Requester 2252 Consideration of Statement and Reply 2209 Reexamination 2253 Consideration by Examiner 2210 Request for Reexamination 2254 Conduct of Reexamination Proceedings 2211 Time for Requesting Examinations 2255 Who Reexamines 2212 Persons Who May File a Request 2256 Prior Art Patents and Printed Publications 2213 Representative of Requester Considered by Examiner in Reexamination 2214 Content of Request 2257 Listing of Prior Art 2215 Fee for Requesting Reexamination 2258 Scope of Reexamination 2216 Substantial New Question of Patentability 2259 Collateral Estoppel In Reexamination 2217 Statement in the Request Applying Prior Art Proceedings 2218 Copies of Prior Art 2260 Office Actions 2219 Copy of Printed Patent 2260.01 Dependent Claims 2220 Certificate of Service 2261 Special Status For Action 2221 Amendments Included in Request by 2262 Form and Content of Office Action Patent Owner -
Reforming Patent Reexamination Procedure for the Small Business and Small Inventor
COMMENT CREATING A VIABLE ALTERNATIVE: REFORMING PATENT REEXAMINATION PROCEDURE FOR THE SMALL BUSINESS AND SMALL INVENTOR WILLIAM BARROW* TABLE OF CONTENTS Introduction ...............................................................................................630 I. Background on Reexamination.......................................................632 A. Ex Parte Reexamination ..........................................................633 B. Inter Partes Reexamination......................................................634 C. Director-Ordered Reexamination............................................635 D. Reexamination’s Amendment Process ....................................636 II. The Shortfalls of Reexamination ....................................................636 A. Ineffectiveness of Ex Parte and Inter Partes Reexamination.....637 B. Restrained Use of Director-Ordered Reexamination...............638 C. Loopholes in the Amendment Process ....................................639 III. Reforming Reexamination..............................................................640 A. Administrative Estoppel via Post-Reexamination Procedure....642 B. Expanded Use of Director-Ordered Reexamination................643 Conclusion ................................................................................................645 * J.D. Candidate, May 2008, American University Washington College of Law; B.S. Electrical Engineering, University of Pennsylvania, 2004. I would like to thank Professor Joshua Sarnoff and Professor Robert Kasunic for their